Please ensure Javascript is enabled for purposes of website accessibility

Minnesota Regulators Plead for the Creation of a Central Pot Authority

By Eric Volkman - Mar 2, 2020 at 6:15PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Officials argue that having one single state agency would be significantly more efficient.

Public health authorities in Minnesota are calling for the state to establish a central regulator for the marijuana business. According to the Minneapolis Star Tribune, officials from four state agencies are lobbying the government for this regulator because the quickly growing cannabis industry is becoming harder for them to monitor and regulate.

The quartet of agencies -- the Pharmacy Board plus the state departments of Agriculture, Public Safety, and Health -- are each responsible for various facets of the cannabis business. Their argument is that having a single entity entrusted with these responsibilities would be more efficient than at present. Some complain that they don't have the time or resources to properly keep pace with a rapidly developing industry.

Minnesota road sign with cannabis leaf.

Image source: Getty Images.

The state's medical marijuana program has grown robustly. The number of patients enrolled it in rose by at annual rate of 27% in 2019, to over 18,000. Following the passage of the federal government's farm bill in late 2018, the number of hemp farmers in this relatively agrarian state has increased exponentially.

In 2014, Minnesota's legislature passed a law permitting medical marijuana. The state has decriminalized recreational use and sale of the drug, although such activities are still technically illegal.

Two marijuana companies, LeafLine Labs and Minnesota Medical Solutions, dominate the dispensary segment in the state. Innovative Industrial Properties (IIPR 4.94%) effected a sale-leaseback transaction with a growth and cultivation facility that Minnesota Medical Solutions' parent, Vireo Health, owned in the town of Otsego, not far from Minneapolis. So far, Innovative has not commented on the future of regulation in Minnesota.

Shares of Innovative closed almost 7% higher on Monday. 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
IIPR
$119.33 (4.94%) $5.62

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
321%
 
S&P 500 Returns
111%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.